These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36473399)
1. Risk of, and risk factors for, vasculopathy associated with acute herpes zoster. Yawn BP; Lindsay AC; Yousefi M; Wang C J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106891. PubMed ID: 36473399 [TBL] [Abstract][Full Text] [Related]
2. Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis. Zhang Y; Luo G; Huang Y; Yu Q; Wang L; Li K J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1807-1816. PubMed ID: 28501259 [TBL] [Abstract][Full Text] [Related]
3. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015. Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194 [TBL] [Abstract][Full Text] [Related]
4. Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. Minassian C; Thomas SL; Smeeth L; Douglas I; Brauer R; Langan SM PLoS Med; 2015 Dec; 12(12):e1001919. PubMed ID: 26671338 [TBL] [Abstract][Full Text] [Related]
5. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Breuer J; Pacou M; Gauthier A; Brown MM Neurology; 2014 Jan; 82(3):206-12. PubMed ID: 24384645 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for herpes zoster: should people with asthma or COPD be vaccinated? Safonova E; Yawn BP; Welte T; Wang C Respir Res; 2023 Jan; 24(1):35. PubMed ID: 36709298 [TBL] [Abstract][Full Text] [Related]
7. Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke. Yang Q; George MG; Chang A; Tong X; Merritt R; Hong Y Neurology; 2020 Aug; 95(6):e708-e717. PubMed ID: 32636330 [TBL] [Abstract][Full Text] [Related]
8. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Breuer J; Pacou M; Gautier A; Brown MM Neurology; 2014 Jul; 83(2):e27-33. PubMed ID: 25002574 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine. Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122 [TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of zoster vaccine live in kidney transplant recipients immunized prior to transplantation: a retrospective single-centre cohort study. Kim SH; Huh K; Lee KW; Park JB; Huh WS; Ko JH; Cho SY; Kang CI; Chung DR; Peck KR Clin Microbiol Infect; 2023 Jul; 29(7):911-917. PubMed ID: 36868356 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the potential public health impact of Herpes Zoster vaccination in Germany. Curran D; Van Oorschot D; Varghese L; Oostvogels L; Mrkvan T; Colindres R; von Krempelhuber A; Anastassopoulou A Hum Vaccin Immunother; 2017 Oct; 13(10):2213-2221. PubMed ID: 28708959 [TBL] [Abstract][Full Text] [Related]
12. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia. Muttucumaru R; Lau CL; Leeb A; Mills DJ; Wood N; Furuya-Kanamori L Vaccine; 2024 May; 42(13):3166-3171. PubMed ID: 38677792 [TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682 [TBL] [Abstract][Full Text] [Related]
15. Herpes Zoster: Epidemiological Links With Stroke and Myocardial Infarction. Warren-Gash C J Infect Dis; 2018 Sep; 218(suppl_2):S102-S106. PubMed ID: 30247593 [TBL] [Abstract][Full Text] [Related]
16. Risk of stroke and transient ischaemic attack after herpes zoster. Kwon SU; Yun SC; Kim MC; Kim BJ; Lee SH; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH Clin Microbiol Infect; 2016 Jun; 22(6):542-8. PubMed ID: 26992774 [TBL] [Abstract][Full Text] [Related]
17. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400 [TBL] [Abstract][Full Text] [Related]
18. Herpes zoster and long-term vascular risk: a retrospective cohort study. Horev A; Horev A; Gordon-Irshai A; Gordon M; Andre N; Ifergane G Sci Rep; 2023 Feb; 13(1):2364. PubMed ID: 36759695 [TBL] [Abstract][Full Text] [Related]
19. Safety of live attenuated herpes zoster vaccine in adults 70-79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program. Totterdell J; Phillips A; Glover C; Chidwick K; Marsh J; Snelling T; Macartney K Vaccine; 2020 May; 38(23):3968-3979. PubMed ID: 32284271 [TBL] [Abstract][Full Text] [Related]
20. Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study. Yang Q; Chang A; Tong X; Merritt R Stroke; 2021 May; 52(5):1712-1721. PubMed ID: 33874749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]